Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Nice Match (3)
286 Articles Available
3
12
Can't find what you're looking for? Try our
advanced search
.
Partnership
Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies
PR-M02-20-NI-025
M&A
Promedior Announces Completion of Acquisition by Roche
PR-M02-20-NI-020
M&A
Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio
PR-M02-20-NI-007
M&A
Catalent Acquires Orgenesis' Cell Therapy Unit
PR-M01-20-NI-046
M&A
Lilly Announces Agreement to Acquire Dermira
PR-M01-20-NI-032
Cell and Gene Therapy
BC Platforms Partners with Dante Labs to Build Europe’s Largest Next Generation Sequencing Laboratory for Private and Public Customers
PR-M01-20-NI-014
M&A
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
PR-M01-20-NI-006
M&A
Charles River Laboratories Completes the Acquisition of HemaCare Corporation
PR-M01-20-NI-005
M&A
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
PR-M12-19-NI-024
M&A
Merck to Acquire ArQule, Advancing Leadership in Oncology
PR-M12-19-NI-017
Collaboration
AbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics
PR-M12-19-NI-021
M&A
Sanofi to Acquire Synthorx to Bolster its Immuno-Oncology Pipeline for $2.5 Billion
PR-M12-19-NI-016
Collaboration
Piramal Pharma Solutions Announces Collaboration with BerGenBio on the Development of FDA Fast Track Designated Leukemia Treatment
PR-M12-19-NI-005
M&A
Novartis to Acquire The Medicines Company for $9.7 Billion
PR-M11-19-NI-031
Partnership
Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease
PR-M11-19-NI-030
Collaboration
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
PR-M11-19-NI-013
M&A
Invitae to Acquire Clear Genetics
PR-M11-19-NI-010
M&A
Sandoz Announces Agreement to Acquire Aspen’s Japanese Operations
PR-M11-19-NI-009
M&A
Stryker Announces Definitive Agreement to Acquire Wright Medical
PR-M11-19-NI-007
Partner
Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510
PR-M11-19-NI-004
Strategic Collaboration
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
PR-M10-19-NI-048
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
PR-M10-19-NI-020
Clinical Trial Partnership
Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials
PR-M10-19-NI-014
Partnership
Charles River Laboratories Joins Dementia Consortium, Reaffirms Commitment to Neuroscience Research
PR-M10-19-NI-013
«
3
12
»
.svg)
